Major Tron (TRON) stake via Series B preferred and large warrant position
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Tron Inc. director and more-than-10% owner Sun Weike filed an initial ownership report showing an indirect stake held through Bravemorning Limited. Bravemorning Limited purchased 100,000 shares of Series B Convertible Preferred Stock, which are convertible into 200,000,000 shares of common stock at a $0.50 conversion price, and warrants to purchase up to 220,000,000 shares of common stock at an exercise price of $0.50 per share. These positions give Sun a substantial potential indirect equity interest if converted or exercised.
Positive
- None.
Negative
- None.
Insights
Form 3 shows a large new preferred and warrant position linked to Tron.
Sun Weike, a director and more-than-10% owner, is linked to significant indirect holdings via Bravemorning Limited. The entity acquired 100,000 Series B preferred shares, convertible into 200,000,000 common shares at $0.50, plus warrants for up to 220,000,000 common shares at the same price.
These are derivative positions rather than common shares today, but they represent substantial potential equity if exercised or converted. The warrants carry an expiration date of June 16, 2027, while the preferred shares have no expiration, providing a long-dated exposure to Tron’s common stock structure.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
SUN Weike
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series B Convertible Preferred Stock | -- | -- | -- |
| holding | Common Stock Purchase Warrants | -- | -- | -- |
Holdings After Transaction:
Series B Convertible Preferred Stock — 200,000,000 shares (Indirect, See footnote);
Common Stock Purchase Warrants — 220,000,000 shares (Indirect, See footnote)
Footnotes (1)
- These securities do not have an expiration date. The reported securities are held directly by Bravemorning Limited. Mr. Weike Sun is the sole shareholder of Bravemorning Limited and may be deemed to beneficially own the securities held by Bravemorning Limited. On June 16, 2025, Bravemorning Limited purchased 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share.
Key Figures
Series B preferred shares: 100,000 shares
Common shares underlying preferred: 200,000,000 shares
Preferred conversion price: $0.50 per share
+3 more
6 metrics
Series B preferred shares
100,000 shares
Held by Bravemorning Limited as of June 16, 2025
Common shares underlying preferred
200,000,000 shares
Convertible from Series B at $0.50 per share
Preferred conversion price
$0.50 per share
Series B Convertible Preferred Stock into common stock
Common shares underlying warrants
220,000,000 shares
Purchase warrants exercisable into common stock
Warrant exercise price
$0.50 per share
Exercise price for common stock purchase warrants
Warrant expiration
June 16, 2027
Expiration date of common stock purchase warrants
Key Terms
Series B Convertible Preferred Stock, Common Stock Purchase Warrants, beneficially own, conversion price, +1 more
5 terms
Series B Convertible Preferred Stock financial
"Bravemorning Limited purchased 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares"
Series B convertible preferred stock is a class of shares sold during a later-stage private financing that combines features of a loan and common stock: it usually pays priority dividends or has a priority claim if the company is sold, and it can be converted into common shares under predefined rules. Investors care because these shares affect ownership stakes and payout order—like having a reserved place in line and a ticket that can turn into regular ownership—so they influence potential returns and dilution for other shareholders.
Common Stock Purchase Warrants financial
"and warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price"
Common stock purchase warrants are tradable instruments that give the holder the right to buy a company’s common shares at a set price before a specified date, like a coupon that lets you purchase stock later at a fixed rate. They matter to investors because they offer a way to gain future upside if the stock rises, but when exercised they increase the number of shares outstanding and can reduce existing shareholders’ ownership and earnings per share.
beneficially own financial
"may be deemed to beneficially own the securities held by Bravemorning Limited"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
conversion price financial
"convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share"
The conversion price is the fixed price at which a convertible security, like a bond or preferred stock, can be exchanged for shares of common stock. It acts like a set rate that determines how many shares an investor can receive if they choose to convert their investment. This helps investors understand the value and potential benefits of converting their securities into company shares.
exercise price financial
"warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider position did Sun Weike report in Tron (TRON) on this Form 3?
Sun Weike reported an indirect ownership position in Tron through Bravemorning Limited. The entity holds Series B Convertible Preferred Stock and common stock purchase warrants that together represent substantial potential common share exposure if converted and exercised at the stated prices.
Is Sun Weike’s Tron (TRON) ownership direct or indirect?
The reported holdings are indirect, held by Bravemorning Limited. Sun Weike is the sole shareholder of Bravemorning Limited and may be deemed to beneficially own the securities that entity holds, including the Series B preferred shares and the common stock purchase warrants.
What prices are attached to the Tron (TRON) preferred stock conversion and warrant exercise?
Both instruments are tied to a $0.50 per share price. The Series B Convertible Preferred Stock converts into common stock at $0.50 per share, and the common stock purchase warrants allow buying up to 220,000,000 common shares at an exercise price of $0.50 per share.